These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 34555356)
21. In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L. Morishita M; Mevius D; di Luccio E BMC Struct Biol; 2014 Dec; 14():25. PubMed ID: 25494638 [TBL] [Abstract][Full Text] [Related]
22. NSD2 inhibition suppresses metastasis in cervical cancer by promoting TGF-β/TGF-βRI/SMADs signaling. Zhu L; Yu CL; Zheng Y Biochem Biophys Res Commun; 2019 Nov; 519(3):489-496. PubMed ID: 31526565 [TBL] [Abstract][Full Text] [Related]
23. NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression. Jeong GY; Park MK; Choi HJ; An HW; Park YU; Choi HJ; Park J; Kim HY; Son T; Lee H; Min KW; Oh YH; Lee JY; Kong G Cancer Res; 2021 Jan; 81(1):77-90. PubMed ID: 32967925 [TBL] [Abstract][Full Text] [Related]
24. A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks. Yuan C; Chen H; Tu S; Huang HY; Pan Y; Gui X; Kuang M; Shen X; Zheng Q; Zhang Y; Cheng C; Hong H; Tao X; Peng Y; Yao X; Meng F; Ji H; Shao Z; Sun Y Genome Biol; 2021 May; 22(1):156. PubMed ID: 34001209 [TBL] [Abstract][Full Text] [Related]
25. Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation. Rajagopalan KN; Chen X; Weinberg DN; Chen H; Majewski J; Allis CD; Lu C Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619101 [TBL] [Abstract][Full Text] [Related]
26. NSD2 promotes ventricular remodelling mediated by the regulation of H3K36me2. Zhou XL; Zhu RR; Wu X; Xu H; Li YY; Xu QR; Liu S; Huang H; Xu X; Wan L; Wu QC; Liu JC J Cell Mol Med; 2019 Jan; 23(1):568-575. PubMed ID: 30334333 [TBL] [Abstract][Full Text] [Related]
27. Loss of TET reprograms Wnt signaling through impaired demethylation to promote lung cancer development. Xu Q; Wang C; Zhou JX; Xu ZM; Gao J; Sui P; Walsh CP; Ji H; Xu GL Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35110400 [TBL] [Abstract][Full Text] [Related]
28. Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation. Popovic R; Martinez-Garcia E; Giannopoulou EG; Zhang Q; Zhang Q; Ezponda T; Shah MY; Zheng Y; Will CM; Small EC; Hua Y; Bulic M; Jiang Y; Carrara M; Calogero RA; Kath WL; Kelleher NL; Wang JP; Elemento O; Licht JD PLoS Genet; 2014 Sep; 10(9):e1004566. PubMed ID: 25188243 [TBL] [Abstract][Full Text] [Related]
30. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis. Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047 [No Abstract] [Full Text] [Related]
33. Systematic perturbations of SETD2, NSD1, NSD2, NSD3, and ASH1L reveal their distinct contributions to H3K36 methylation. Shipman GA; Padilla R; Horth C; Hu B; Bareke E; Vitorino FN; Gongora JM; Garcia BA; Lu C; Majewski J Genome Biol; 2024 Oct; 25(1):263. PubMed ID: 39390582 [TBL] [Abstract][Full Text] [Related]
34. Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma. He C; Liu C; Wang L; Sun Y; Jiang Y; Hao Y Cell Death Dis; 2019 Jan; 10(2):65. PubMed ID: 30683853 [TBL] [Abstract][Full Text] [Related]
35. YTHDF1 Promotes Cyclin B1 Translation through m Lou X; Ning J; Liu W; Li K; Qian B; Xu D; Wu Y; Zhang D; Cui W Cells; 2021 Jul; 10(7):. PubMed ID: 34359836 [TBL] [Abstract][Full Text] [Related]
36. The T1150A cancer mutant of the protein lysine dimethyltransferase NSD2 can introduce H3K36 trimethylation. Khella MS; Schnee P; Weirich S; Bui T; Bröhm A; Bashtrykov P; Pleiss J; Jeltsch A J Biol Chem; 2023 Jun; 299(6):104796. PubMed ID: 37150325 [TBL] [Abstract][Full Text] [Related]
37. An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia. Swaroop A; Oyer JA; Will CM; Huang X; Yu W; Troche C; Bulic M; Durham BH; Wen QJ; Crispino JD; MacKerell AD; Bennett RL; Kelleher NL; Licht JD Oncogene; 2019 Jan; 38(5):671-686. PubMed ID: 30171259 [TBL] [Abstract][Full Text] [Related]
38. MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK-3β/β-catenin signalling. Shi Y; Xu Y; Yao J; Yan C; Su H; Zhang X; Chen E; Ying K J Cell Mol Med; 2021 Jul; 25(14):7013-7027. PubMed ID: 34121323 [TBL] [Abstract][Full Text] [Related]
39. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma. Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818 [TBL] [Abstract][Full Text] [Related]
40. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells. Ma S; Wang X; Zhang Z; Liu D Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]